Plain-English translation of NCT06513247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This research study is testing whether a simple blood screening program can identify children who are at high risk of developing type 1 diabetes before symptoms appear. Researchers will take a small blood sample from children who have a close family member (parent or sibling) with type 1 diabetes, and test it for genetic and immune markers that predict disease risk. If you qualify, you may be invited to return for follow-up visits over the next 5 years to monitor whether you progress toward the disease.
Type 1 diabetes is becoming more common in Saudi Arabia, and early detection of at-risk children could allow doctors to start treatments that delay or even prevent the disease from developing. Currently, Saudi Arabia does not have an organized screening program, which means many at-risk children are not identified until they already have symptoms—sometimes with dangerous complications.
You likely qualify if…
You likely don't qualify if…
At your first visit, researchers will collect a small blood sample (using a special filter paper) to test for genetic and immune markers. If the initial results show you are at risk, you will be invited back for follow-up appointments over the next 5 years to monitor whether these markers change. Throughout the study, you will also be asked about your symptoms and health history to help researchers understand how screening affects early detection and family education.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Saudi Arabia